Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI ...
Through its patient-data-derived Gemini digital twins, Aitia is uncovering the hidden genetic and molecular mechanisms that causally drive human disease, and accelerating the discovery of breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results